Phase 3 N=1,388 Randomized Single-blind Prevention

Preoperative CHG Cloth on Healthy Subjects

Surgery

Bottom Line

View on ClinicalTrials.gov: NCT02291601 ↗

Enrolled (actual)

1,388

Serious AEs

0.0%

Results posted

Apr 2021

Primary outcome: Primary: Percent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites — 80; 75; 86; 65 % of Treated Sites

Study Design & Population

Study type: Interventional
Phase: Phase 3
Interventions: Chlorhexidine Gluconate (Drug); Vehicle (Other); DynaHex-2 (Drug)
Age: Pediatric, Adult, Older Adult · 16+ yrs
Sex: All
Sponsor: Medline Industries
Primary completion: Sep 2015

Outcome Measures

Outcome	Result	p-value
PRIMARY Percent Responder Rates of Bacterial Reduction on the Abdomen and Groin Sites	80; 75; 86; 65; 81; 68	—

Summary

Evaluate the effects of CHG cloth on the reduction of bacteria on the skin.

Eligibility Criteria

Inclusion Criteria

Males or Females
16 years of age or older
Signed informed consent
Good Health
Six inches of abdomen and groin areas without tattoos, or skin disorders

Exclusion Criteria

Dermatological Conditions
Sensitivity to latex
Sensitivity to CHG

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02291601). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.